Total Payments
$9,584
2024 Payments
$462.52
Companies
18
Transactions
131
Medicare Patients
304
Medicare Billing
$153,696
Payment Breakdown by Category
Other$6,160 (64.3%)
Food & Beverage$3,214 (33.5%)
Education$209.96 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,160 | 4 | 64.3% |
| Food and Beverage | $3,214 | 123 | 33.5% |
| Education | $209.96 | 4 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $6,773 | 32 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $605.08 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $354.38 | 10 | $0 (2022) |
| ABBVIE INC. | $288.16 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $276.93 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $269.26 | 8 | $0 (2024) |
| Lundbeck LLC | $205.28 | 11 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $193.60 | 5 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $145.43 | 3 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $111.32 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.52 | 21 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($111.32) |
| 2023 | $692.57 | 32 | AbbVie Inc. ($210.22) |
| 2022 | $260.30 | 8 | Otsuka America Pharmaceutical, Inc. ($144.32) |
| 2020 | $4,496 | 10 | Allergan, Inc. ($4,430) |
| 2019 | $2,982 | 35 | Allergan Inc. ($2,045) |
| 2018 | $209.17 | 6 | Otsuka America Pharmaceutical, Inc. ($141.85) |
| 2017 | $481.28 | 19 | Allergan Inc. ($245.86) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: ADHD | ||||||
| 08/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: PSYCHIATRY | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.62 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 05/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PSYCHIATRY | ||||||
| 03/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Neuroscience | ||||||
| 03/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: PSYCHIATRY | ||||||
| 03/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.02 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 72 | 408 | $108,120 | $37,670 |
| 2022 | 2 | 84 | 324 | $85,860 | $29,894 |
| 2021 | 2 | 74 | 444 | $117,590 | $44,361 |
| 2020 | 2 | 74 | 450 | $119,250 | $41,772 |
Total Patients
304
Total Services
1,626
Medicare Billing
$153,696
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 204 | $46,920 | $19,340 | 41.2% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2023 | 36 | 204 | $61,200 | $18,329 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 162 | $37,260 | $15,240 | 40.9% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 42 | 162 | $48,600 | $14,654 | 30.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 223 | $51,290 | $23,160 | 45.2% |
| 90838 | Psychotherapy with evaluation and management visit, 60 minutes | Office | 2021 | 37 | 221 | $66,300 | $21,201 | 32.0% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 37 | 225 | $67,500 | $21,882 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 225 | $51,750 | $19,890 | 38.4% |
About Dr. Janet Scholle, MD
Dr. Janet Scholle, MD is a Psychiatry healthcare provider based in Wpb, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124076302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janet Scholle, MD has received a total of $9,584 in payments from pharmaceutical and medical device companies, with $462.52 received in 2024. These payments were reported across 131 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,160).
As a Medicare-enrolled provider, Scholle has provided services to 304 Medicare beneficiaries, totaling 1,626 services with total Medicare billing of $153,696. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Wpb, FL
- Active Since 05/04/2006
- Last Updated 08/15/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124076302
Products in Payments
- VRAYLAR (Drug) $7,042
- REXULTI (Drug) $741.60
- LATUDA (Drug) $354.38
- SPRAVATO (Drug) $269.26
- INGREZZA (Drug) $193.60
- Trintellix (Drug) $149.98
- CAPLYTA (Drug) $146.45
- TRINTELLIX (Drug) $145.95
- AUSTEDO (Drug) $119.71
- HETLIOZ (Drug) $58.58
- VYVANSE (Drug) $55.89
- JORNAY PM (Drug) $42.03
- Evekeo (Drug) $36.94
- Auvelity (Drug) $30.29
- SERTRALINE HCL (Drug) $28.35
- Austedo XR (Drug) $25.72
- LOREEV XR (Drug) $23.39
- BRINTELLIX (Drug) $22.62
- Fanapt (Drug) $19.16
- VIIBRYD (Drug) $18.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.